Fairfield Financial Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Fairfield Financial Advisors's AMGN Position: Q2 2026 in Review
Fairfield Financial Advisors reduced its Amgen (AMGN) stake by 8% in Q2 2026, selling an estimated $141K and leaving 4,758 shares worth $1.72M. The position accounts for 0.68% of the portfolio, ranked #32.
Fairfield Financial Advisors first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.67M in Q3 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Fairfield Financial Advisors held 4,758 shares of Amgen worth $1.72M as of Q2 2026.
- Fairfield Financial Advisors sold 413 Amgen shares in Q2 2026, an estimated $141K.
- Amgen made up 0.68% of Fairfield Financial Advisors's portfolio in Q2 2026, its #32 holding.
- Fairfield Financial Advisors first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
- Fairfield Financial Advisors's Amgen position peaked at $2.67M in Q3 2024.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Fairfield Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.